Kenai Therapeutics Raises $82M in Series A Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Ryne Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ryne Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ryne Bio Today - Breaking & Trending Today
Kenai Therapeutics Announces 82 Million Series A Financing to Advance Next Generation Allogeneic Cell Therapies for Neurological Diseases
Kenai Therapeutics a biotechnology company leveraging induced pluripotent stem cell iPSC technology to discover and develop a platform of allogeneic neuron replacement cell therapies for neurological disorders today announced an 82 million Series A financing coled by Alaska Permanent Fund Corporation Cure Ventures and The Column Group with participation from Euclidean Capital and Saisei Ventures.
Source: businesswireindia.com
Dopamine Stem Cell Replacement Therapy Clinical Trials Market Trends Insight |
Global Dopamine Cell Replacement Therapy Clinical Trials, Companies & Market Trends Insight 2023 Report Highlights: Research Methodology Global
Source: medgadget.com
Discrimination Linked to Frailty in African American Cancer Survivors
Among African American cancer survivors, experiencing discrimination is associated with deficit accumulation.
Source: oncologynurseadvisor.com